Plants Yield Polio Vaccine Breakthrough
Breakthrough in Zika Vaccine Development
Diabetes Drug Could Be Potential Parkinson’s Treatment
23andMe Recruiting for Depression, Bipolar Study
A well-known consumer genetic testing firm has initiated enrollment for a novel study aimed at exploring the biological underpinnings of major depressive and bipolar disorders. 23andMe is working with the Milken Institute and Lundbeck Pharmaceuticals on a trial that seeks to recruit 25,000 people diagnosed with these conditions, which will be split between 15,000 participants…
Eli Lilly’s Acute Migraine Treatment Meets Goal in Phase III Study
Precision Medicine Method Could Lead to New C. Diff Treatment
Merck’s Keytruda Missed Survival Goal in Phase III Study
Eli Lilly Signs Development Deal for Novel Immunology Drug
Vertex Reveals Promising Data for Triple Combination Cystic Fibrosis Therapies
Breakthrough Could Yield Novel Schizophrenia Treatment
Bioverativ R&D Chief Breaks Down Data on Blood Disorder Drug Pipeline
FDA Panel Recommends Approval for Novartis CAR-T Cell Therapy
FDA Chief Reveals Plan for Streamlining Drug Approval Process
Report Predicts Huge Growth for Heart Failure Treatment Space
Novartis’ Entresto could lead the charge on an impressive uptick in growth for the heart failure treatment space, according to a new analysis from research and consulting firm GlobalData. The report predicts the market value for these treatments will go from $3.7 billion in 2016 to an estimated $16.1 billion by 2026 signifying an increase…
Biogen Unveils More Study Data for Spinraza at SMA 2017
Microneedle Patch Could Replace Traditional Flu Vaccines
John Oliver Defends Vaccinations in New Segment
John Oliver, the host of HBO’s Last Week Tonight, is no stranger to criticizing the pharmaceutical industry with segments on the opioid epidemic and marketing practices targeting physicians. This week, however, the comedian took a different route by arguing in support of vaccinations after a re-emergence of people advocating that these injections are linked to…
Nevada Governor Signs Strict Drug Pricing Transparency Bill
Nevada has joined the growing group of states looking for new ways to combat high prescription drug prices. Republican Governor Brian Sandoval signed a bipartisan bill into law on Thursday that is the first-in-the-nation diabetes drug transparency bill, according to the Nevada Independent. The legislation, labeled SB539, requires manufacturers of diabetes drugs as well as…